For example, MLN4924 can inhibit NF-κB inflammation but cannot improve mitochondrial dysfunction; however, combined use of a URM1 agonist and MLN4924 can simultaneously alleviate inflammation and mitochondrial injury in the IRI-AKI model, significantly improving renal protective effects [48,61]. The gene discussed is NFKB1; the disease is acute kidney injury.